Maze Therapeutics, Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.71-$17
Market Cap
$525.3M
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$167.5M
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$167.5M
Diluted EPS
-$0.42

News

See more

Yahoo Finance • last month

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

Yahoo Finance • 3 months ago

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease

About

CEO
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
CFO
Ms. Amy Bachrodt
Address
171 Oyster Point Blvd, South San Francisco, CA, United States, 94080
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
125